RecallRadar

FDA Drug recall D-0608-2018

Evamist (estradiol transdermal spray), 1.53mg estradiol/spray, 0.27 fl oz (8.1 mL) per bottle, Rx Only, Manufactured for Perrigo, Minneapol…

On 2018-04-04 the FDA classified a Class II recall of Evamist (estradiol transdermal spray), 1.53mg estradiol/spray, 0.27 fl oz (8.1 mL) per bottle, Rx Only, Manufactured for Perrigo, Minneapol… by Paddock Laboratories, citing defective Delivery System: Potential that cracks in the vial neck near the crimp may result in product evaporation and/or leaking and the inability to properly dispense product.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0608-2018
ClassificationClass II
Statusterminated
Initiated2018-02-26
Published2018-04-04
Last updated2026-09-13 11:52 UTC
CompanyPaddock Laboratories
DistributionUS

Product

Evamist (estradiol transdermal spray), 1.53mg estradiol/spray, 0.27 fl oz (8.1 mL) per bottle, Rx Only, Manufactured for Perrigo, Minneapolis, MN 55427. NDC: 0574-2067-27

Reason

Defective Delivery System: Potential that cracks in the vial neck near the crimp may result in product evaporation and/or leaking and the inability to properly dispense product.

Identifiers

ndc0574-2067-27
ndc0574-2067-00
code_infoLot: MEEF Exp. 04/2020

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0608-2018%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.